Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Lee, Su Y ^a   Jeon, Hyun M ^a   Kim, Cho H ^a,c   Ju, Min K ^a   Bae, Hye S ^a   Park, Hye G ^a   Lim, Sung Chul ^b   Han, Song I ^b   Kang, Ho S ^a  

^a Pusan National University   (South Korea)

^b Chosun University   (South Korea)

^c National Forensic Service   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; ANTIGEN DLX 2; ANTIGEN DLX-2; GLUCOSE; MEMBRANE ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CANCER CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; DISTAL-LESS 2 GENE; GENE EXPRESSION; GENE INDUCTION; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; METABOLIC STRESS; TUMOR NECROSIS; TUMOR SPHEROID; APOPTOSIS; BREAST TUMOR; CELL AGGREGATION; COLON TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NECROSIS; NEOPLASM; OVARY TUMOR; PATHOLOGY; PERMEABILITY; PHYSIOLOGICAL STRESS; RNA INTERFERENCE; TUMOR CELL LINE;

ANTIGENS, SURFACE; APOPTOSIS; BREAST NEOPLASMS; CELL AGGREGATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NECROSIS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PERMEABILITY; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; STRESS, PHYSIOLOGICAL; TETRADECANOYLPHORBOL ACETATE;

EID: 80052849532     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-113     Document Type: Article

References (49)

1. Tomes L, Emberley E, Niu Y, Troup S, Pastorek J, Strange K, Harris A, Watson PH. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res Treat 2003, 81:61-69. 10.1023/A:1025476722493, 14531498.
2. Kunz M, Ibrahim SM. Molecular responses to hypoxia in tumor cells. Mol Cancer 2003, 2:23. 10.1186/1476-4598-2-23, 155638, 12740039.
3. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899. 10.1038/nrc1478, 15516961.
4. Jin S, DiPaola RS, Mathew R, White E. Metabolic catastrophe as a means to cancer cell death. J Cell Sci 2007, 120:379-383. 10.1242/jcs.03349, 2857576, 17251378.
5. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 2007, 3:28-31. 2770734, 16969128.
6. Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006, 20:1-15. 10.1101/gad.1376506, 16391229.
7. Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 2007, 32:37-43. 10.1016/j.tibs.2006.11.001, 17141506.
8. Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004, 4:641-648. 10.1038/nri1415, 15286730.
9. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899. 10.1016/j.cell.2010.01.025, 2866629, 20303878.
10. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
11. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-342. 10.1038/nri1594, 15803152.
12. Schlueter C, Weber H, Meyer B, Rogalla P, Roser K, Hauke S, Bullerdiek J. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 2005, 166:1259-1263. 10.1016/S0002-9440(10)62344-9, 1602384, 15793304.
13. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360. 10.1038/35012626, 10830965.
14. Kang R, Livesey KM, Zeh HJ, Loze MT, Tang D. HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy 2010, 6:1209-1211. 10.4161/auto.6.8.13651, 20935509.
15. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310. 10.1038/onc.2010.261, 2945431, 20622903.
16. Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010, 1799:131-140. 2818552, 20123075.
17. Merlo GR, Zerega B, Paleari L, Trombino S, Mantero S, Levi G. Multiple functions of Dlx genes. Int J Dev Biol 2000, 44:619-626.
18. Panganiban G, Rubenstein JL. Developmental functions of the Distal-less/Dlx homeobox genes. Development 2002, 129:4371-4386.
19. Kraus P, Lufkin T. Dlx homeobox gene control of mammalian limb and craniofacial development. Am J Med Genet A 2006, 140:1366-1374.
20. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence?. Nat Rev Cancer 2002, 2:777-785. 10.1038/nrc907, 12360280.
21. Samuel S, Naora H. Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur J Cancer 2005, 41:2428-2437. 10.1016/j.ejca.2005.08.014, 16199152.
22. Hennessy BT, Mills GB. Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling. Int J Biochem Cell Biol 2006, 38:1450-1456. 10.1016/j.biocel.2006.01.009, 16682246.
23. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26:6766-6776. 10.1038/sj.onc.1210760, 17934484.
24. Hara F, Samuel S, Liu J, Rosen D, Langley RR, Naora H. A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2. Am J Pathol 2007, 170:1594-1606. 10.2353/ajpath.2007.061025, 1854954, 17456765.
25. Man YG, Fu SW, Schwartz A, Pinzone JJ, Simmens SJ, Berg PE. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat 2005, 90:241-247. 10.1007/s10549-004-4492-9, 15830137.
26. Tan Y, Timakhov RA, Rao M, Altomare DA, Xu J, Liu Z, Gao Q, Jhanwar SC, Di Cristofano A, Wiest DL, et al. A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice. Cancer Res 2008, 68:1296-1302. 10.1158/0008-5472.CAN-07-3218, 18316591.
27. Tan Y, Cheung M, Pei J, Menges CW, Godwin AK, Testa JR. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling. Cancer Res 2010, 70:9197-9206. 10.1158/0008-5472.CAN-10-1568, 21045156.
28. Kato T, Sato N, Takano A, Miyamoto M, Nishimura H, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients. Clin Cancer Res 2008, 14:2363-2370. 10.1158/1078-0432.CCR-07-1523, 18413826.
29. Morini M, Astigiano S, Gitton Y, Emionite L, Mirisola V, Levi G, Barbieri O. Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231. BMC Cancer 2010, 10:649. 10.1186/1471-2407-10-649, 3003273, 21108812.
30. Xu J, Testa JR. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC. J Biol Chem 2009, 284:20593-20601. 10.1074/jbc.M109.021477, 2742824, 19497851.
31. Shimamoto T, Nakamura S, Bollekens J, Ruddle FH, Takeshita K. Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis. Proc Natl Acad Sci USA 1997, 94:3245-3249. 10.1073/pnas.94.7.3245, 20354, 9096378.
32. Kim CH, Han SI, Lee SY, Youk HS, Moon JY, Duong HQ, Park MJ, Joo YM, Park HG, Kim YJ, et al. Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J Cell Physiol 2007, 211:371-385. 10.1002/jcp.20941, 17309078.
33. Kim CH, Jeon HM, Lee SY, Ju MK, Moon JY, Park HG, Yoo MA, Choi BT, Yook JI, Lim SC, et al. Implication of Snail in Metabolic Stress-induced Necrosis. PLoS One 2011,
34. Ahmad IM, Aykin-Burns N, Sim JE, Walsh SA, Higashikubo R, Buettner GR, Venkataraman S, Mackey MA, Flanagan SW, Oberley LW, Spitz DR. Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem 2005, 280:4254-4263.
35. Spitz DR, Sim JE, Ridnour LA, Galoforo SS, Lee YJ. Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?. Ann N Y Acad Sci 2000, 899:349-362.
36. Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 2009, 418:29-37. 10.1042/BJ20081258, 2678564, 18937644.
37. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK, Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008, 5:849-862. 10.1021/mp800047v, 18680382.
38. Ivascu A, Kubbies M. Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 2007, 31:1403-1413.
39. Jeong EK, Lee SY, Jeon HM, Ju MK, Kim CH, Kang HS. Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells. Int J Oncol 2010, 37:655-661.
40. LaRue KE, Khalil M, Freyer JP. Microenvironmental regulation of proliferation in multicellular spheroids is mediated through differential expression of cyclin-dependent kinase inhibitors. Cancer Res 2004, 64:1621-1631. 10.1158/0008-5472.CAN-2902-2, 14996720.
41. Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006, 27:639-645. 10.1016/j.tips.2006.10.005, 17056127.
42. Muller FL, Liu Y, Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 2004, 279:49064-49073. 10.1074/jbc.M407715200, 15317809.
43. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003, 304:463-470. 10.1016/S0006-291X(03)00618-1, 12729580.
44. Kim CH, Jeon HM, Lee SY, Jeong EK, Ju MK, Park BJ, Park HG, Lim SC, Han SI, Kang HS. Role of reactive oxygen species-dependent protein aggregation in metabolic stress-induced necrosis. Int J Oncol 2010, 37:97-102.
45. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000, 192:1001-1014. 10.1084/jem.192.7.1001, 2193314, 11015441.
46. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 2006, 1757:509-517. 10.1016/j.bbabio.2006.04.029, 16829228.
47. Alirol E, Martinou JC. Mitochondria and cancer: is there a morphological connection?. Oncogene 2006, 25:4706-4716. 10.1038/sj.onc.1209600, 16892084.
48. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662. 10.1038/sj.onc.1209607, 16892079.
49. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004, 18:1272-1282. 10.1101/gad.1199904, 420353, 15145826.